DPC4 gene mutation in colitis associated neoplasia

A. T M S Hoque, S. A. Hahn, M. Schutte, Scott E Kern

Research output: Contribution to journalArticle

Abstract

Background - Colitis associated dysplasia and cancer often have deletions involving the long arm of chromosome 18q, suggesting the location of a tumour suppressor gene critical for their tumorigenesis. The DPC4 gene, which is genetically inactivated in pancreatic and other cancers, has recently been described. Aim - Because DPC4 is located at 18q21.1, the hypothesis that it could be a mutated tumour suppressor gene in colitis associated neoplasms was tested. Patients - Advanced neoplastic lesions from six patients having chronic colitis were analysed for DPC4. Methods - Individual exons of DPC4 were amplified by the polymerase chain reaction (PCR) and sequenced from genomic DNA of tissue specimens dissected by cryostat. Results DPC4 was found to have biallelic inactivation in one of three neoplasms shown to have allelic loss of 18q. The mutation had been acquired somatically in a plaque of high grade dysplasia. The mutation created a non-sense codon, which would cause premature termination of protein translation. Conclusion - The DPC4 gene is a target of 18q LOH events in colitis associated neoplasia.

Original languageEnglish (US)
Pages (from-to)120-122
Number of pages3
JournalGut
Volume40
Issue number1
StatePublished - 1997

Fingerprint

Colitis
Mutation
Tumor Suppressor Genes
Translational Peptide Chain Termination
Genes
Neoplasms
Loss of Heterozygosity
Pancreatic Neoplasms
Codon
Exons
Carcinogenesis
Chromosomes
Polymerase Chain Reaction
DNA

Keywords

  • In vitro synthesis
  • In vitro synthesised protein assay
  • LOH
  • Loss of heterozygosity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hoque, A. T. M. S., Hahn, S. A., Schutte, M., & Kern, S. E. (1997). DPC4 gene mutation in colitis associated neoplasia. Gut, 40(1), 120-122.

DPC4 gene mutation in colitis associated neoplasia. / Hoque, A. T M S; Hahn, S. A.; Schutte, M.; Kern, Scott E.

In: Gut, Vol. 40, No. 1, 1997, p. 120-122.

Research output: Contribution to journalArticle

Hoque, ATMS, Hahn, SA, Schutte, M & Kern, SE 1997, 'DPC4 gene mutation in colitis associated neoplasia', Gut, vol. 40, no. 1, pp. 120-122.
Hoque ATMS, Hahn SA, Schutte M, Kern SE. DPC4 gene mutation in colitis associated neoplasia. Gut. 1997;40(1):120-122.
Hoque, A. T M S ; Hahn, S. A. ; Schutte, M. ; Kern, Scott E. / DPC4 gene mutation in colitis associated neoplasia. In: Gut. 1997 ; Vol. 40, No. 1. pp. 120-122.
@article{44af4bff6d064889889e8267fc7a0b68,
title = "DPC4 gene mutation in colitis associated neoplasia",
abstract = "Background - Colitis associated dysplasia and cancer often have deletions involving the long arm of chromosome 18q, suggesting the location of a tumour suppressor gene critical for their tumorigenesis. The DPC4 gene, which is genetically inactivated in pancreatic and other cancers, has recently been described. Aim - Because DPC4 is located at 18q21.1, the hypothesis that it could be a mutated tumour suppressor gene in colitis associated neoplasms was tested. Patients - Advanced neoplastic lesions from six patients having chronic colitis were analysed for DPC4. Methods - Individual exons of DPC4 were amplified by the polymerase chain reaction (PCR) and sequenced from genomic DNA of tissue specimens dissected by cryostat. Results DPC4 was found to have biallelic inactivation in one of three neoplasms shown to have allelic loss of 18q. The mutation had been acquired somatically in a plaque of high grade dysplasia. The mutation created a non-sense codon, which would cause premature termination of protein translation. Conclusion - The DPC4 gene is a target of 18q LOH events in colitis associated neoplasia.",
keywords = "In vitro synthesis, In vitro synthesised protein assay, LOH, Loss of heterozygosity",
author = "Hoque, {A. T M S} and Hahn, {S. A.} and M. Schutte and Kern, {Scott E}",
year = "1997",
language = "English (US)",
volume = "40",
pages = "120--122",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - DPC4 gene mutation in colitis associated neoplasia

AU - Hoque, A. T M S

AU - Hahn, S. A.

AU - Schutte, M.

AU - Kern, Scott E

PY - 1997

Y1 - 1997

N2 - Background - Colitis associated dysplasia and cancer often have deletions involving the long arm of chromosome 18q, suggesting the location of a tumour suppressor gene critical for their tumorigenesis. The DPC4 gene, which is genetically inactivated in pancreatic and other cancers, has recently been described. Aim - Because DPC4 is located at 18q21.1, the hypothesis that it could be a mutated tumour suppressor gene in colitis associated neoplasms was tested. Patients - Advanced neoplastic lesions from six patients having chronic colitis were analysed for DPC4. Methods - Individual exons of DPC4 were amplified by the polymerase chain reaction (PCR) and sequenced from genomic DNA of tissue specimens dissected by cryostat. Results DPC4 was found to have biallelic inactivation in one of three neoplasms shown to have allelic loss of 18q. The mutation had been acquired somatically in a plaque of high grade dysplasia. The mutation created a non-sense codon, which would cause premature termination of protein translation. Conclusion - The DPC4 gene is a target of 18q LOH events in colitis associated neoplasia.

AB - Background - Colitis associated dysplasia and cancer often have deletions involving the long arm of chromosome 18q, suggesting the location of a tumour suppressor gene critical for their tumorigenesis. The DPC4 gene, which is genetically inactivated in pancreatic and other cancers, has recently been described. Aim - Because DPC4 is located at 18q21.1, the hypothesis that it could be a mutated tumour suppressor gene in colitis associated neoplasms was tested. Patients - Advanced neoplastic lesions from six patients having chronic colitis were analysed for DPC4. Methods - Individual exons of DPC4 were amplified by the polymerase chain reaction (PCR) and sequenced from genomic DNA of tissue specimens dissected by cryostat. Results DPC4 was found to have biallelic inactivation in one of three neoplasms shown to have allelic loss of 18q. The mutation had been acquired somatically in a plaque of high grade dysplasia. The mutation created a non-sense codon, which would cause premature termination of protein translation. Conclusion - The DPC4 gene is a target of 18q LOH events in colitis associated neoplasia.

KW - In vitro synthesis

KW - In vitro synthesised protein assay

KW - LOH

KW - Loss of heterozygosity

UR - http://www.scopus.com/inward/record.url?scp=0031057713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031057713&partnerID=8YFLogxK

M3 - Article

C2 - 9155588

AN - SCOPUS:0031057713

VL - 40

SP - 120

EP - 122

JO - Gut

JF - Gut

SN - 0017-5749

IS - 1

ER -